MindBio Therapeutics (XCNQ:MBIO) Total Stockholders Equity : C$-4.95 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is MindBio Therapeutics Total Stockholders Equity?

MindBio Therapeutics's Total Stockholders Equity for the quarter that ended in Mar. 2024 was C$-4.95 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. MindBio Therapeutics's Book Value per Share for the quarter that ended in Mar. 2024 was C$-0.04. The ratio of a company's debt over equity can be used to measure how leveraged this company is. MindBio Therapeutics's Debt-to-Equity for the quarter that ended in Mar. 2024 was -0.91.

MindBio Therapeutics Total Stockholders Equity Historical Data

The historical data trend for MindBio Therapeutics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MindBio Therapeutics Total Stockholders Equity Chart

MindBio Therapeutics Annual Data

Trend

Jun21

Jun22

Jun23

Total Stockholders Equity

-0.45

-3.80

-4.78

MindBio Therapeutics Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial					-3.92	-4.78	-4.88	-5.07	-4.95

MindBio Therapeutics (XCNQ:MBIO) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

MindBio Therapeutics's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-4.95	-	0)	/	133.047
	=	-0.04

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

MindBio Therapeutics's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.955	+	3.545)	/	-4.95
	=	-0.91

MindBio Therapeutics Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of MindBio Therapeutics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

MindBio Therapeutics (XCNQ:MBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MindBio Therapeutics Corp (XCNQ:MBIO) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

WF6:Germany

Address

91-97 William Street, Level 4, Melbourne, VIC, AUS, 3000

Website

https://www.mindbiotherapeutics.com

MindBio Therapeutics Corp is pioneering clinical studies into the microdosing of psychedelic medicines to treat a range of medical conditions such as depression, anxiety, PTSD, panic disorder, chronic pain and opiate addictions. Its clinical trials microdosing of psychedelic medicines provide hope for sufferers of mental health conditions with new emerging treatment alternatives. The company invests in clinical research to discover potential new treatment options and aims to create novel medicines and treatment regimes from breakthrough microdosing studies. Geographically, the activities of the company takes place in Australia.